Are labs required for patients using GLP-1 for weight loss only
All prescriptions are based on medical evaluation and eligibility
On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List
Varin EM, Mulvihill EE, Baggio LL, Koehler JA, Cao X, Seeley RJ, et al
Its a once-daily pill and will now become available for private prescription, but it still under review by the National Institute for Health and Care Excellence (NICE) for use in the NHS
18 Baseline (complication-free) utilities were estimated using a multivariable regression model informed by nationally representative, patient level data from the 2017 and 2018 Health Survey for England